GLD Acquires Seelos Therapeutics’ Assets, Strengthening GLD’s Growing Life Sciences Portfolio
GLD Announces Successful Closing of Seelos Assets; Includes Ketamine and Trehalose Programs Advancing into Phase 3 Clinical Trials
Read MoreAlternative Investment with Vision.Integrity.Discipline.
GLD is a private investment firm focused on long-term value across biopharma, credit, and private equity.
Private Investment, Done Right.
We are focused on generating strong risk-adjusted returns. We invest with discipline, operate with rigor, and align our interests with those of our investors and portfolio companies.
Our approach is built on market expertise, careful capital allocation, and a long-term orientation. We navigate complexity and deliver consistent performance across market cycles.
Where We Invest.
Biopharma
We back biopharma platforms with the science to change how medicine works and the discipline to bring them to market.
Credit
We invest across the full credit spectrum, from traditional debt to distressed and private credit, with one goal: finding value where others don't look.
Equity
We find businesses others overlook and help them reach their potential through smart capital, focused strategy, and active management.
Real Estate
We invest in undervalued, underleveraged real estate where capital and repositioning can unlock real returns.An Integrated Approach to Research, Risk & Value
Research
Our teams work independently, covering sectors and geographies that larger, more centralized research operations tend to overlook.
Risk Management
One consistent framework across every strategy we run — covering portfolio construction, stress testing, and capital allocation.
Value Creation
We invest with patience and stay invested. Sustainable growth and operational strength always win over short-term gains.
Advancing Drug Delivery
Altanine, Inc.
Altanine is developing drug-delivery technologies that make therapies more precise and more effective. We invested because we believe great science deserves the right platform to scale.
Join Our Team
We’re looking for people who are intellectually curious, take their work seriously, and want to build something that lasts. If that sounds like you, we’d love to talk.
Latest News & Perspectives
GLD Launches New Biotech Company, Altagenics, to Accelerate Drug Discovery for Muscle-Wasting Diseases
In collaboration with Heligenics GigaAssay™ platform, the companies will speed the development of new therapies in aging-related diseases.
Read MoreLet's Talk
Whether you're an investor, a potential partner, or just curious - we'd love to hear from you.
By Contacting us, you agree to our Terms of Service
and Privacy Policy